First Allied Advisory Services’s Accelerate Diagnostics AXDX Stock Holding History

First Allied Advisory Services’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,243	Closed	-$239K	–	1081
2014 Q4	$239K	Sell	1,243 -219	-15%	-$46.9K	0.02%	858
2014 Q3	$314K	Buy	1,462 +144	+11%	+$28K	0.02%	708
2014 Q2	$344K	Buy	+1,318	New	+$288K	0.03%	660

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Allied Advisory Services's AXDX Position: Q1 2015 in Review

First Allied Advisory Services sold out of Accelerate Diagnostics (AXDX) in Q1 2015, closing a stake of 1,243 shares — an estimated $239K sold.

First Allied Advisory Services first reported a position in AXDX in Q2 2014 and held it in 3 quarters. The position peaked at $344K in Q2 2014. 75 funds tracked by Wall St. Rank hold AXDX as of Q1 2015.

First Allied Advisory Services reported no remaining Accelerate Diagnostics position as of Q1 2015 after selling out during the quarter.
First Allied Advisory Services sold 1,243 Accelerate Diagnostics shares in Q1 2015, an estimated $239K.
First Allied Advisory Services first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 3 quarters.
First Allied Advisory Services's Accelerate Diagnostics position peaked at $344K in Q2 2014.
75 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2015.

Based on First Allied Advisory Services's 13F filing for Q1 2015, filed 15 May 2015.